5AM Ventures logo

5AM Ventures

North America, California, United States, Menlo Park

Description

5AM Ventures is a venture capital firm that aims to finance seed and early-stage life sciences companies.

Investor Profile

5AM Ventures has made 176 investments, with 7 in the past 12 months and 32% as lead.

Stage Focus

  • Series A (36%)
  • Series B (28%)
  • Series C (13%)
  • Series Unknown (6%)
  • Post Ipo Equity (6%)
  • Series D (6%)
  • Seed (2%)
  • Private Equity (1%)
  • Series G (1%)
  • Convertible Note (1%)

Country Focus

  • United States (91%)
  • Switzerland (4%)
  • United Kingdom (2%)
  • Sweden (1%)
  • Canada (1%)
  • Singapore (1%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Pharmaceutical
  • Life Science
  • Biopharma
  • Genetics
  • Medical Device
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does 5AM Ventures frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 25
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 11
New Leaf Venture Partners
North America, New York, United States, New York
Co-Investments: 15
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 15
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 11
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 31
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 16
OUP (Osage University Partners)
North America, Pennsylvania, United States, Bala Cynwyd
Co-Investments: 13
Roche Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 15
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 14

Which angels does 5AM Ventures often collaborate with?

AS
North America, New York, United States, New York
Shared Deals: 1
Dennis Chan
North America, California, United States, Menlo Park
Shared Deals: 1
PT
North America, California, United States, San Francisco
Shared Deals: 1
JG
North America, California, United States, Culver City
Shared Deals: 1
ED
North America, New York, United States, New York
Shared Deals: 1
AZ
North America, California, United States, Mountain View
Shared Deals: 1
AW
North America, California, United States, San Francisco
Shared Deals: 1
SW
North America, California, United States, Mountain View
Shared Deals: 1
RS
North America, Washington, United States, Seattle
Shared Deals: 4

What are some of recent deals done by 5AM Ventures?

Surrozen

South San Francisco, California, United States

Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.

BiotechnologyEmergency MedicineHealth Care
Post Ipo EquityMar 24, 2025
Amount Raised: $175,000,000
Latigo Biotherapeutics

Thousand Oaks, California, United States

Latigo Biotherapeutics is a clinical-stage biotechnology company that develops novel, non-opioid therapies for chronic pain.

BiotechnologyHealth CareMedicalTherapeutics
Series BMar 17, 2025
Amount Raised: $150,000,000
nChroma Bio

Boston, Massachusetts, United States

nChroma Bio is a cutting-edge biotechnology business that is developing targeted in vivo delivery systems as well as best-in-class cargo.

BiotechnologyMedicalProduct Research
Series UnknownDec 11, 2024
Amount Raised: $75,000,000
TMRW Life Sciences

New York, New York, United States

TMRW Life Sciences provides an integrated platform for automated, software-guided cryospecimen management.

BiotechnologyHealth CareLife ScienceSoftware
Series DJul 12, 2024
Amount Raised: $28,172,940
RareCyte

Seattle, Washington, United States

RareCyte is a life science research and diagnostic development company focused on characterizing and isolating rare cells in the blood.

BiotechnologyHealth CareHealth DiagnosticsMedical Device
Series UnknownJun 27, 2024
Amount Raised: $20,000,000
Tectonic Therapeutic

Allston, Massachusetts, United States

Tectonic Therapeutic is a biotechnology company which focuses on scientific research in biochemistry and molecular pharmacology.

Biotechnology
Post Ipo EquityJun 20, 2024
Amount Raised: $130,700,000
Karius

Redwood City, California, United States

Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.

BiotechnologyGeneticsHealth CareInformation TechnologyLife SciencePrecision Medicine
Series CMay 2, 2024
Amount Raised: $100,000,000
Latigo Biotherapeutics

Thousand Oaks, California, United States

Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.

Health CareMedicalTherapeutics
Series AFeb 14, 2024
Amount Raised: $135,000,000
Adverum Biotechnologies

Menlo Park, California, United States

Adverum Biotechnologies is a gene therapy company that focuses on developing medicines that can offer therapeutic benefits to patients.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo EquityFeb 5, 2024
Amount Raised: $127,500,000
Silence Therapeutics

London, England, United Kingdom

Silence Therapeutics is a drug development company with a proprietary genetic medicine platform.

BiotechnologyHealth CareInformation TechnologyMedicalTherapeutics
Post Ipo EquityFeb 2, 2024
Amount Raised: $120,000,000